# Short-course Antimicrobial Therapy for Paediatric Respiratory Infections

> **NCT02380352** · PHASE4 · COMPLETED · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 281 (actual)

## Conditions studied

- Community-acquired Pneumonia

## Interventions

- **DRUG:** Amoxicillin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02380352
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2019-12
- **Final completion:** 2020-04
- **Target enrollment:** 281 (ACTUAL)
- **Last updated:** 2021-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02380352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02380352, "Short-course Antimicrobial Therapy for Paediatric Respiratory Infections". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02380352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*